Jun 2026 (Q2 FY26) — Aug 4, 2026
Hinge Health Q2 FY26 — Strong Growth, Margin Expansion, and Strategic GI Acquisition
Read the full callHinge Health (HNGE) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Hinge Health earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 213 | +53.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 19.0 | +436.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 43.7 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$103.96 +4.84% · +$4.8
Performance +111.0% 1Y
1Y: $49.28 on 17 Oct 2025 → $103.96. High $105.14 (13 Oct 2026), low $31.17 (6 Feb 2026).
- Previous close
- $99.16
- 52-week range
- $31.17 – $105.14
- One year
- +102.73%
Overview
- Symbol
- HNGE
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — May 5, 2026
Hinge Health Q1 FY26 — Strong Financials and Migraine Program Launch
Read the full callEvery analysed call
Hinge Health earnings calls (HNGE)
Financials
What the filings say
Net profit, year on year: +108% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 117 | 124 | 139 | 154 | 171 | 182 | 213 |
| Operating profit | -4 | 21 | 13 | -581 | -6 | 27 | 32 | 40 |
| Operating margin | −3.8% | 17.8% | 10.6% | −417.4% | −4.0% | 16.0% | 17.6% | 19.0% |
| Other income | 5 | 5 | 5 | 5 | 4 | 5 | 4 | 4 |
| Profit before tax | 1 | 26 | 18 | -576 | -2 | 32 | 36 | 44 |
| Tax rate | 76.5% | −3.6% | 5.5% | 0.1% | −12.6% | 0.4% | 2.3% | 1.7% |
| Net profit | 0 | 27 | 17 | -576 | -2 | 32 | 35 | 44 |
| EPS ($ per share) | 0.01 | — | 7.91 | -13.10 | -0.02 | — | 0.43 | 0.55 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Equity capital | — | 0 | — |
| Reserves | — | -523 | -1,051 |
| Total liabilities | — | 257 | 366 |
| Fixed assets | — | 7 | 10 |
| Investments | — | 166 | — |
| Total assets | — | 673 | 745 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Cash from operations | -64 | 49 | 171 |
| Cash from investing | 2 | 18 | -114 |
| Cash from financing | -3 | -2 | -150 |
| Capital expenditure | -2 | -1 | -1 |
| Free cash flow | -66 | 48 | 171 |
HNGE revenue by segment
| Segment | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|
| Reportable | 100% | 100% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
HNGE operating KPIs by quarter
| KPI | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Provider locations Hinge Select | 4,100We ended Q1 with 4,100 provider locations, and we're also thrilled to share that we recently expanded Hinge Select access through 1 of our national PBM partners and 3 of the 5 largest national health plans by self-insured lives.Source: earnings call transcript | 5,000+We've also expanded our provider network spanning over 5,000 locations now.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Insider filings
302 filings between Nov 18, 2025 and Oct 12, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$543.07M
206 sales by 8 insiders
82% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 7
- Award — granted as compensation
- 24
- Tax withheld — shares kept back by the company to cover tax
Also filed: 59 conversions, 5 gifts, 1 other.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Insight Holdings Group, LLC | — | $343.54M | Jul 9, 2026 |
| Mecklenburg Gabriel M.I. | — | $90.44M | Oct 12, 2026 |
| Perez Daniel Antonio | — | $53.56M | Oct 6, 2026 |
| Bessemer Venture Partners X L.P. | — | $29.04M | Nov 18, 2025 |
| Budge James | — | $14.28M | Oct 12, 2026 |
| Pursley James | — | $11.79M | Sep 21, 2026 |
| Leslie Kristina M | — | $417.7K | Aug 20, 2026 |
| Robinson Elliott | — | $0 | Sep 14, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 59,988 | $6.21M |
| Oct 12, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 9,420 | $982.8K |
| Oct 12, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 39,868 | $4.16M |
| Oct 12, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 91,502 | $9.38M |
| Oct 12, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 21,702 | $2.23M |
| Oct 12, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 2,100 | $213.2K |
| Oct 12, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 8,642 | $877.4K |
| Oct 12, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 14,498 | $1.50M |
| Oct 12, 2026 | Mecklenburg Gabriel M.I. Director | Conversion 10b5-1 plan | 200,000 | $0 |
| Oct 6, 2026 | Perez Daniel Antonio CEO & Co-Founder | Conversion 10b5-1 plan | 4,100 | $0 |
| Oct 6, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 4,100 | $410.8K |
| Oct 5, 2026 | Sloat Tyler Director | Award | 175 | $16.2K |
| Oct 1, 2026 | Budge James Chief Financial Officer | Tax withheld | 4,614 | $448.7K |
| Oct 1, 2026 | Pursley James President | Tax withheld | 831 | $80.8K |
| Sep 21, 2026 | Pursley James President | Sale 10b5-1 plan | 9,065 | $846.4K |
| Sep 21, 2026 | Pursley James President | Sale 10b5-1 plan | 800 | $76.1K |
| Sep 21, 2026 | Pursley James President | Sale 10b5-1 plan | 23,135 | $2.18M |
| Sep 14, 2026 | Robinson Elliott Director | Sale | 0 | $0 |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. Director | Conversion 10b5-1 plan | 150,000 | $0 |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 29,298 | $2.77M |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 16,540 | $1.52M |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 2,800 | $249.1K |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 11,700 | $1.07M |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 56,161 | $5.22M |
| Sep 14, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 33,501 | $3.15M |
| Sep 11, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 73,241 | $6.57M |
| Sep 11, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 11,724 | $1.06M |
| Sep 11, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 45,533 | $4.01M |
| Sep 11, 2026 | Mecklenburg Gabriel M.I. Director | Conversion 10b5-1 plan | 250,000 | $0 |
| Sep 11, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 113,707 | $10.09M |
| Sep 11, 2026 | Mecklenburg Gabriel M.I. Director | Sale 10b5-1 plan | 5,795 | $504.3K |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 42,740 | $3.85M |
| Sep 10, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 13,261 | $1.17M |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 24,599 | $2.19M |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 24,390 | $2.15M |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Conversion 10b5-1 plan | 145,000 | $0 |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 1,630 | $149.3K |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 17,740 | $1.61M |
| Sep 10, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 800 | $73.3K |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 58,076 | $5.23M |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 35,303 | $3.14M |
| Sep 10, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 5,910 | $536.4K |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 37,251 | $3.29M |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Conversion 10b5-1 plan | 150,000 | $0 |
| Sep 10, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 21,783 | $1.96M |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Gift 10b5-1 plan | 45,000 | $0 |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 1,100 | $100.8K |
| Sep 10, 2026 | Budge James Chief Financial Officer | Sale 10b5-1 plan | 13,807 | $1.23M |
| Sep 10, 2026 | Perez Daniel Antonio CEO & Co-Founder | Sale 10b5-1 plan | 7,171 | $652.2K |
| Sep 9, 2026 | Robinson Elliott Director | Sale | 0 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Hinge Health, Inc.
Free account. Everything above stays public.
Write why you follow Hinge Health, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading